Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8684 |
High Similarity |
NPD5426 |
Phase 3 |
0.8453 |
Intermediate Similarity |
NPD6595 |
Phase 3 |
0.8389 |
Intermediate Similarity |
NPD749 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD482 |
Approved |
0.8325 |
Intermediate Similarity |
NPD7000 |
Clinical (unspecified phase) |
0.8325 |
Intermediate Similarity |
NPD6999 |
Discontinued |
0.8315 |
Intermediate Similarity |
NPD2096 |
Phase 2 |
0.8315 |
Intermediate Similarity |
NPD2091 |
Phase 2 |
0.8299 |
Intermediate Similarity |
NPD5901 |
Discontinued |
0.827 |
Intermediate Similarity |
NPD6610 |
Clinical (unspecified phase) |
0.8261 |
Intermediate Similarity |
NPD2095 |
Phase 2 |
0.8261 |
Intermediate Similarity |
NPD2094 |
Phase 2 |
0.8261 |
Intermediate Similarity |
NPD2092 |
Phase 2 |
0.809 |
Intermediate Similarity |
NPD7998 |
Clinical (unspecified phase) |
0.8077 |
Intermediate Similarity |
NPD750 |
Phase 2 |
0.8071 |
Intermediate Similarity |
NPD7001 |
Phase 3 |
0.8065 |
Intermediate Similarity |
NPD5728 |
Clinical (unspecified phase) |
0.805 |
Intermediate Similarity |
NPD8013 |
Clinical (unspecified phase) |
0.8043 |
Intermediate Similarity |
NPD6203 |
Clinical (unspecified phase) |
0.8021 |
Intermediate Similarity |
NPD3607 |
Clinical (unspecified phase) |
0.802 |
Intermediate Similarity |
NPD6987 |
Phase 1 |
0.799 |
Intermediate Similarity |
NPD7665 |
Phase 2 |
0.799 |
Intermediate Similarity |
NPD7666 |
Phase 3 |
0.798 |
Intermediate Similarity |
NPD6732 |
Clinical (unspecified phase) |
0.7967 |
Intermediate Similarity |
NPD4184 |
Clinical (unspecified phase) |
0.796 |
Intermediate Similarity |
NPD7470 |
Discontinued |
0.7958 |
Intermediate Similarity |
NPD6180 |
Clinical (unspecified phase) |
0.794 |
Intermediate Similarity |
NPD8493 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD8431 |
Approved |
0.7838 |
Intermediate Similarity |
NPD5065 |
Approved |
0.7822 |
Intermediate Similarity |
NPD7809 |
Clinical (unspecified phase) |
0.7817 |
Intermediate Similarity |
NPD8248 |
Clinical (unspecified phase) |
0.78 |
Intermediate Similarity |
NPD4862 |
Clinical (unspecified phase) |
0.7773 |
Intermediate Similarity |
NPD6164 |
Phase 2 |
0.7773 |
Intermediate Similarity |
NPD6165 |
Phase 2 |
0.7766 |
Intermediate Similarity |
NPD7621 |
Clinical (unspecified phase) |
0.7766 |
Intermediate Similarity |
NPD8464 |
Clinical (unspecified phase) |
0.7755 |
Intermediate Similarity |
NPD7948 |
Phase 1 |
0.7749 |
Intermediate Similarity |
NPD4426 |
Clinical (unspecified phase) |
0.7745 |
Intermediate Similarity |
NPD7594 |
Clinical (unspecified phase) |
0.7745 |
Intermediate Similarity |
NPD4852 |
Phase 2 |
0.774 |
Intermediate Similarity |
NPD6242 |
Discontinued |
0.7734 |
Intermediate Similarity |
NPD7825 |
Clinical (unspecified phase) |
0.7729 |
Intermediate Similarity |
NPD8405 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD484 |
Approved |
0.7723 |
Intermediate Similarity |
NPD2509 |
Approved |
0.7723 |
Intermediate Similarity |
NPD2510 |
Approved |
0.7692 |
Intermediate Similarity |
NPD5575 |
Clinical (unspecified phase) |
0.7673 |
Intermediate Similarity |
NPD6838 |
Clinical (unspecified phase) |
0.7668 |
Intermediate Similarity |
NPD8110 |
Clinical (unspecified phase) |
0.7653 |
Intermediate Similarity |
NPD7619 |
Phase 3 |
0.7653 |
Intermediate Similarity |
NPD7944 |
Discontinued |
0.7653 |
Intermediate Similarity |
NPD7618 |
Phase 3 |
0.765 |
Intermediate Similarity |
NPD8073 |
Approved |
0.7624 |
Intermediate Similarity |
NPD7958 |
Clinical (unspecified phase) |
0.7624 |
Intermediate Similarity |
NPD7957 |
Phase 1 |
0.7624 |
Intermediate Similarity |
NPD2008 |
Discontinued |
0.7622 |
Intermediate Similarity |
NPD2844 |
Phase 3 |
0.7585 |
Intermediate Similarity |
NPD8112 |
Clinical (unspecified phase) |
0.7573 |
Intermediate Similarity |
NPD2411 |
Approved |
0.7573 |
Intermediate Similarity |
NPD8093 |
Discontinued |
0.7549 |
Intermediate Similarity |
NPD7947 |
Clinical (unspecified phase) |
0.7536 |
Intermediate Similarity |
NPD8094 |
Discontinued |
0.7526 |
Intermediate Similarity |
NPD4079 |
Approved |
0.7526 |
Intermediate Similarity |
NPD4076 |
Approved |
0.7525 |
Intermediate Similarity |
NPD4848 |
Phase 1 |
0.7525 |
Intermediate Similarity |
NPD8072 |
Approved |
0.7512 |
Intermediate Similarity |
NPD5818 |
Discontinued |
0.7487 |
Intermediate Similarity |
NPD6664 |
Approved |
0.7486 |
Intermediate Similarity |
NPD4374 |
Clinical (unspecified phase) |
0.7477 |
Intermediate Similarity |
NPD7603 |
Discontinued |
0.7474 |
Intermediate Similarity |
NPD3505 |
Approved |
0.7474 |
Intermediate Similarity |
NPD2144 |
Approved |
0.7474 |
Intermediate Similarity |
NPD3506 |
Approved |
0.7473 |
Intermediate Similarity |
NPD276 |
Clinical (unspecified phase) |
0.7463 |
Intermediate Similarity |
NPD4601 |
Approved |
0.7463 |
Intermediate Similarity |
NPD4600 |
Approved |
0.7461 |
Intermediate Similarity |
NPD6178 |
Phase 3 |
0.7449 |
Intermediate Similarity |
NPD4499 |
Approved |
0.7448 |
Intermediate Similarity |
NPD3178 |
Discontinued |
0.7444 |
Intermediate Similarity |
NPD2172 |
Phase 1 |
0.7442 |
Intermediate Similarity |
NPD4845 |
Discontinued |
0.7438 |
Intermediate Similarity |
NPD2121 |
Clinical (unspecified phase) |
0.7437 |
Intermediate Similarity |
NPD7818 |
Clinical (unspecified phase) |
0.7433 |
Intermediate Similarity |
NPD5069 |
Clinical (unspecified phase) |
0.7431 |
Intermediate Similarity |
NPD7950 |
Approved |
0.7431 |
Intermediate Similarity |
NPD7952 |
Approved |
0.7431 |
Intermediate Similarity |
NPD7789 |
Approved |
0.7431 |
Intermediate Similarity |
NPD7953 |
Approved |
0.7431 |
Intermediate Similarity |
NPD7951 |
Approved |
0.7431 |
Intermediate Similarity |
NPD7790 |
Approved |
0.7431 |
Intermediate Similarity |
NPD7791 |
Approved |
0.7429 |
Intermediate Similarity |
NPD8406 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD786 |
Approved |
0.7418 |
Intermediate Similarity |
NPD6995 |
Phase 1 |
0.7409 |
Intermediate Similarity |
NPD3320 |
Approved |
0.7409 |
Intermediate Similarity |
NPD3318 |
Approved |
0.7409 |
Intermediate Similarity |
NPD3319 |
Phase 1 |
0.7407 |
Intermediate Similarity |
NPD7780 |
Approved |
0.7407 |
Intermediate Similarity |
NPD7781 |
Approved |
0.7404 |
Intermediate Similarity |
NPD8458 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD5473 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD1326 |
Approved |
0.7394 |
Intermediate Similarity |
NPD1325 |
Approved |
0.7389 |
Intermediate Similarity |
NPD5721 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD3389 |
Approved |
0.7381 |
Intermediate Similarity |
NPD3393 |
Approved |
0.7381 |
Intermediate Similarity |
NPD3394 |
Approved |
0.7371 |
Intermediate Similarity |
NPD7564 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD4736 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD8488 |
Clinical (unspecified phase) |
0.7361 |
Intermediate Similarity |
NPD7730 |
Approved |
0.7361 |
Intermediate Similarity |
NPD7731 |
Approved |
0.7359 |
Intermediate Similarity |
NPD6530 |
Approved |
0.7359 |
Intermediate Similarity |
NPD6531 |
Approved |
0.7358 |
Intermediate Similarity |
NPD3038 |
Discontinued |
0.7356 |
Intermediate Similarity |
NPD198 |
Clinical (unspecified phase) |
0.7354 |
Intermediate Similarity |
NPD3914 |
Clinical (unspecified phase) |
0.7354 |
Intermediate Similarity |
NPD5934 |
Clinical (unspecified phase) |
0.7352 |
Intermediate Similarity |
NPD5040 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD6454 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD7271 |
Approved |
0.7348 |
Intermediate Similarity |
NPD4463 |
Approved |
0.7348 |
Intermediate Similarity |
NPD4462 |
Approved |
0.7347 |
Intermediate Similarity |
NPD4948 |
Discontinued |
0.7345 |
Intermediate Similarity |
NPD1722 |
Approved |
0.734 |
Intermediate Similarity |
NPD5017 |
Discontinued |
0.7337 |
Intermediate Similarity |
NPD1038 |
Approved |
0.733 |
Intermediate Similarity |
NPD4075 |
Phase 2 |
0.7327 |
Intermediate Similarity |
NPD6137 |
Clinical (unspecified phase) |
0.7323 |
Intermediate Similarity |
NPD2336 |
Approved |
0.7323 |
Intermediate Similarity |
NPD6630 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD3947 |
Discontinued |
0.7313 |
Intermediate Similarity |
NPD5003 |
Discontinued |
0.731 |
Intermediate Similarity |
NPD1534 |
Approved |
0.7296 |
Intermediate Similarity |
NPD6217 |
Discontinued |
0.7294 |
Intermediate Similarity |
NPD5801 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD7824 |
Approved |
0.7293 |
Intermediate Similarity |
NPD3100 |
Discontinued |
0.7292 |
Intermediate Similarity |
NPD7865 |
Approved |
0.7268 |
Intermediate Similarity |
NPD2837 |
Discontinued |
0.7264 |
Intermediate Similarity |
NPD8000 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD7970 |
Approved |
0.7251 |
Intermediate Similarity |
NPD7971 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD6661 |
Clinical (unspecified phase) |
0.724 |
Intermediate Similarity |
NPD6375 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD8272 |
Phase 2 |
0.7228 |
Intermediate Similarity |
NPD2880 |
Discontinued |
0.7225 |
Intermediate Similarity |
NPD4051 |
Discontinued |
0.722 |
Intermediate Similarity |
NPD2879 |
Approved |
0.722 |
Intermediate Similarity |
NPD2881 |
Approved |
0.7216 |
Intermediate Similarity |
NPD2481 |
Approved |
0.7216 |
Intermediate Similarity |
NPD2479 |
Phase 3 |
0.7211 |
Intermediate Similarity |
NPD1573 |
Approved |
0.7211 |
Intermediate Similarity |
NPD1575 |
Approved |
0.7206 |
Intermediate Similarity |
NPD4500 |
Approved |
0.7206 |
Intermediate Similarity |
NPD4501 |
Approved |
0.72 |
Intermediate Similarity |
NPD3404 |
Approved |
0.7198 |
Intermediate Similarity |
NPD7568 |
Phase 1 |
0.7196 |
Intermediate Similarity |
NPD2639 |
Approved |
0.7196 |
Intermediate Similarity |
NPD2642 |
Approved |
0.7192 |
Intermediate Similarity |
NPD4397 |
Phase 1 |
0.719 |
Intermediate Similarity |
NPD4614 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD4128 |
Approved |
0.7184 |
Intermediate Similarity |
NPD6176 |
Phase 1 |
0.7181 |
Intermediate Similarity |
NPD3323 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD5088 |
Discontinued |
0.7178 |
Intermediate Similarity |
NPD2307 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD3961 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD3486 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD6141 |
Clinical (unspecified phase) |
0.7165 |
Intermediate Similarity |
NPD8386 |
Phase 2 |
0.7164 |
Intermediate Similarity |
NPD802 |
Phase 2 |
0.7164 |
Intermediate Similarity |
NPD1304 |
Clinical (unspecified phase) |
0.7163 |
Intermediate Similarity |
NPD3905 |
Phase 3 |
0.7163 |
Intermediate Similarity |
NPD8322 |
Phase 2 |
0.7158 |
Intermediate Similarity |
NPD2185 |
Clinical (unspecified phase) |
0.7156 |
Intermediate Similarity |
NPD7711 |
Discontinued |
0.715 |
Intermediate Similarity |
NPD5592 |
Clinical (unspecified phase) |
0.715 |
Intermediate Similarity |
NPD56 |
Approved |
0.715 |
Intermediate Similarity |
NPD8098 |
Approved |
0.715 |
Intermediate Similarity |
NPD8283 |
Approved |
0.715 |
Intermediate Similarity |
NPD8282 |
Approved |
0.7137 |
Intermediate Similarity |
NPD5483 |
Clinical (unspecified phase) |
0.7136 |
Intermediate Similarity |
NPD7187 |
Phase 2 |
0.7129 |
Intermediate Similarity |
NPD2443 |
Approved |
0.7129 |
Intermediate Similarity |
NPD2442 |
Approved |
0.7128 |
Intermediate Similarity |
NPD1291 |
Clinical (unspecified phase) |
0.7128 |
Intermediate Similarity |
NPD6277 |
Clinical (unspecified phase) |
0.7122 |
Intermediate Similarity |
NPD2305 |
Discontinued |
0.7122 |
Intermediate Similarity |
NPD6479 |
Discontinued |
0.7114 |
Intermediate Similarity |
NPD5505 |
Discontinued |
0.7114 |
Intermediate Similarity |
NPD4922 |
Phase 2 |
0.7113 |
Intermediate Similarity |
NPD4181 |
Approved |
0.7101 |
Intermediate Similarity |
NPD4886 |
Phase 2 |
0.7101 |
Intermediate Similarity |
NPD7393 |
Clinical (unspecified phase) |
0.71 |
Intermediate Similarity |
NPD3871 |
Clinical (unspecified phase) |
0.71 |
Intermediate Similarity |
NPD3870 |
Clinical (unspecified phase) |
0.7094 |
Intermediate Similarity |
NPD6449 |
Clinical (unspecified phase) |
0.7092
|
Intermediate Similarity |
NPD4383 |
Clinical (unspecified phase) |